The Traders Video Training Library is a comprehensive, detailed collection of special presentation video recordings (each 60 minutes in length on average) from the original Traders Boardroom, run by Davin Clarke and Stuart Young. #
Traders Video Training Library inclusions…
Video training library, which currently contains over 160 videos, on average each 60 minutes in length, covering a wide range of topics including:
- trade strategies
- trade and money management
- market prep
- trading software
- trading psychology
- record keeping
- analysis and expectancy
- trade review session recordings (trades reviewed by Davin Clarke)
- and more !
Click to view our complete, categorised video listing.
PLUS Complimentary use of our best-in-class Ultimate moving average crossover NinjaTrader indicator for the period of your active subscription.
The video library is awesome mate… so many good videos on there!
~ Robert H., Australia
I always get lots from your presentations. What you show us, saves a massive amount of time in trial and error
~ Don K., Queensland
I have said in the past your subscription fees represent excellent value and the monthly fee for the Traders Boardroom plus TMR Indicator Bundle is a price I would pay just to get access to the wealth of knowledge you and Davin provide in the video library alone.
~ Mark M., Australia
As a result of changes in the industry we are evaluating the best trading products and solutions to offer.
Some products will relaunch in Q3 2023 and some new ones will arrive.
Thanks for your understanding and patience.
# Trading financial derivatives (including but not limited to Futures, Forex, CFDs and Options) contains substantial risk and is not suitable for everyone. An investor or trader could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or lifestyle. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading.
Past performance is not indicative of future results. View Full Risk Disclosure.